Bibliotecas PUC-SP - Busca Integrada

Neoadjuvant Therapy for Breast Cancer as a Model for Translational Research

Tekijä Cigdem Selli, Andrew H Sims
Julkaisussa Breast Cancer: Basic and Clinical Research (2019-02-01)

Evaluation of Gene Expression Data From Cybrids and Tumours Highlights Elevated -Driven Proliferation in Triple-Negative Breast Cancer

Tekijä Akanksha Mishra, Maria Bonello, Adam Byron, Simon P Langdon, Andrew H Sims
Julkaisussa Breast Cancer: Basic and Clinical Research (2020-06-01)

T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity

Tekijä Marta Canel, David Taggart, Andrew H Sims, David W Lonergan, Irene C Waizenegger, Alan Serrels
Julkaisussa eLife (2020-01-01)

Wnt pathway activity in breast cancer sub-types and stem-like cells.

Tekijä Rebecca Lamb, Matthew P Ablett, Katherine Spence, Göran Landberg, Andrew H Sims, Robert B Clarke
Julkaisussa PLoS ONE (2013-01-01)

Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapy.

Tekijä Dana Faratian, Andrew H Sims, Peter Mullen, Charlene Kay, Inhwa Um, Simon P Langdon, David J Harrison
Julkaisussa PLoS ONE (2011-01-01)

GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment

Tekijä Ernestina M. De Francesco, Andrew H. Sims, Marcello Maggiolini, Federica Sotgia, Michael P. Lisanti, Robert B. Clarke
Julkaisussa Breast Cancer Research (2017-12-01)

The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.

Tekijä Bin Wang, Linsey E Lindley, Virneliz Fernandez-Vega, Megan E Rieger, Andrew H Sims, Karoline J Briegel
Julkaisussa PLoS ONE (2012-01-01)

On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

Tekijä Richard J. Bownes, Arran K. Turnbull, Carlos Martinez-Perez, David A. Cameron, Andrew H. Sims, Olga Oikonomidou
Julkaisussa Breast Cancer Research (2019-06-01)

Correction: An Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer.

Tekijä Elad Katz, Sylvie Dubois-Marshall, Andrew H. Sims, Philippe Gautier, Helen Caldwell, Richard R. Meehan, David J. Harrison
Julkaisussa PLoS ONE (2011-01-01)

Correction: An Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer.

Tekijä Elad Katz, Sylvie Dubois-Marshall, Andrew H. Sims, Philippe Gautier, Helen Caldwell, Richard R. Meehan, David J. Harrison
Julkaisussa PLoS ONE (2011-01-01)

Correction: An Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer.

Tekijä Elad Katz, Sylvie Dubois-Marshall, Andrew H. Sims, Philippe Gautier, Helen Caldwell, Richard R. Meehan, David J. Harrison
Julkaisussa PLoS ONE (2011-01-01)

Correction: An Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer.

Tekijä Elad Katz, Sylvie Dubois-Marshall, Andrew H. Sims, Philippe Gautier, Helen Caldwell, Richard R. Meehan, David J. Harrison
Julkaisussa PLoS ONE (2011-01-01)

Correction: An Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer.

Tekijä Elad Katz, Sylvie Dubois-Marshall, Andrew H. Sims, Philippe Gautier, Helen Caldwell, Richard R. Meehan, David J. Harrison
Julkaisussa PLoS ONE (2011-01-01)

An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer.

Tekijä Elad Katz, Sylvie Dubois-Marshall, Andrew H Sims, Philippe Gautier, Helen Caldwell, Richard R Meehan, David J Harrison
Julkaisussa PLoS ONE (2011-02-01)

Increased STAT1 signaling in endocrine-resistant breast cancer.

Tekijä Rui Huang, Dana Faratian, Andrew H Sims, Danielle Wilson, Jeremy S Thomas, David J Harrison, Simon P Langdon
Julkaisussa PLoS ONE (2014-01-01)

HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer

Tekijä Edward J. Jarman, Carol Ward, Arran K. Turnbull, Carlos Martinez-Perez, James Meehan, Chrysi Xintaropoulou, Andrew H. Sims, Simon P. Langdon
Julkaisussa Breast Cancer Research (2019-01-01)

The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis

Tekijä Marianna Talia, Ernestina Marianna De Francesco, Damiano Cosimo Rigiracciolo, Maria Grazia Muoio, Lucia Muglia, Antonino Belfiore, Marcello Maggiolini, Andrew H. Sims, Rosamaria Lappano
Julkaisussa Cells (2020-03-01)

Functional Transcription Factor Target Networks Illuminate Control of Epithelial Remodelling

Tekijä Ian M. Overton, Andrew H. Sims, Jeremy A. Owen, Bret S. E. Heale, Matthew J. Ford, Alexander L. R. Lubbock, Erola Pairo-Castineira, Abdelkader Essafi
Julkaisussa Cancers (2020-09-01)

Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours

Tekijä Cigdem Selli, Arran K. Turnbull, Dominic A. Pearce, Ang Li, Anu Fernando, Jimi Wills, Lorna Renshaw, Jeremy S. Thomas, J. Michael Dixon, Andrew H. Sims
Julkaisussa Breast Cancer Research (2019-01-01)

Activation of the S100A7/RAGE Pathway by IGF-1 Contributes to Angiogenesis in Breast Cancer

Tekijä Maria Grazia Muoio, Marianna Talia, Rosamaria Lappano, Andrew H. Sims, Veronica Vella, Francesca Cirillo, Livia Manzella, Marika Giuliano, Marcello Maggiolini, Antonino Belfiore, Ernestina Marianna De Francesco
Julkaisussa Cancers (2021-02-01)